CC
KITE

Carlson Capital’s Kite Pharma, Inc. KITE Stock Holding History

Carlson Capital’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-355,000
Closed -$63.8M – 285
2017
Q3 		$63.8M Buy
+355,000
New +$49.5M 1.09% 15

Carlson Capital's KITE Position: Q4 2017 in Review

Carlson Capital sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 355,000 shares — an estimated $63.8M sold.

Carlson Capital first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $63.8M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Carlson Capital reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Carlson Capital sold 355,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $63.8M.
  • Carlson Capital first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Carlson Capital's Kite Pharma, Inc. position peaked at $63.8M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Carlson Capital's 13F filing for Q4 2017, filed 14 Feb 2018.